Wolf MM - Search Results

1

The definition of refractoriness to platelet transfusions.

Bishop JF, Matthews JP, Yuen K, McGrath K, Wolf MM, Szer J. Bishop JF, et al. Among authors: wolf mm. Transfus Med. 1992 Mar;2(1):35-41. doi: 10.1111/j.1365-3148.1992.tb00132.x. Transfus Med. 1992. PMID: 1308461

2

Transient platelet and HLA antibody formation in multitransfused patients with malignancy.

McGrath K, Wolf M, Bishop J, Veale M, Ayberk H, Szer J, Cooper I, Whiteside M. McGrath K, et al. Br J Haematol. 1988 Mar;68(3):345-50. doi: 10.1111/j.1365-2141.1988.tb04212.x. Br J Haematol. 1988. PMID: 3355793

3

Detection of HLA antibodies by platelet crossmatching techniques.

McGrath K, Holdsworth R, Veale M, Bishop J, Wolf M. McGrath K, et al. Transfusion. 1988 May-Jun;28(3):214-6. doi: 10.1046/j.1537-2995.1988.28388219145.x. Transfusion. 1988. PMID: 3285524

4

Factors influencing 20-hour increments after platelet transfusion.

Bishop JF, Matthews JP, McGrath K, Yuen K, Wolf MM, Szer J. Bishop JF, et al. Among authors: wolf mm. Transfusion. 1991 Jun;31(5):392-6. doi: 10.1046/j.1537-2995.1991.31591263191.x. Transfusion. 1991. PMID: 2048176

5

Clinical factors influencing the efficacy of pooled platelet transfusions.

Bishop JF, McGrath K, Wolf MM, Matthews JP, De Luise T, Holdsworth R, Yuen K, Veale M, Whiteside MG, Cooper IA, et al. Bishop JF, et al. Among authors: wolf mm. Blood. 1988 Feb;71(2):383-7. Blood. 1988. PMID: 3337903 Free article.

6

A randomized study of high-dose cytarabine in induction in acute myeloid leukemia.

Bishop JF, Matthews JP, Young GA, Szer J, Gillett A, Joshua D, Bradstock K, Enno A, Wolf MM, Fox R, Cobcroft R, Herrmann R, Van Der Weyden M, Lowenthal RM, Page F, Garson OM, Juneja S. Bishop JF, et al. Among authors: wolf mm. Blood. 1996 Mar 1;87(5):1710-7. Blood. 1996. PMID: 8634416 Free article. Clinical Trial.

7

A randomised trial of dexamethasone, lorazepam and prochlorperazine for emesis in patients receiving chemotherapy.

Bishop JF, Matthews JP, Wolf MM, Oliver IN, Reynolds S, Walpole E, Rischin D, Buchanan L, Tan LG. Bishop JF, et al. Among authors: wolf mm. Eur J Cancer. 1992;28(1):47-50. doi: 10.1016/0959-8049(92)90382-c. Eur J Cancer. 1992. PMID: 1567690 Clinical Trial.

8

Randomized, double-blind, cross-over study comparing prochlorperazine and lorazepam with high-dose metoclopramide and lorazepam for the control of emesis in patients receiving cytotoxic chemotherapy.

Bishop JF, Wolf M, Matthews JP, Scott K, Ackland S, Yuen K, Morton C, Hillcoat BL, Cooper IA. Bishop JF, et al. Cancer Treat Rep. 1987 Nov;71(11):1007-11. Cancer Treat Rep. 1987. PMID: 3315193 Clinical Trial.

9

A randomised double blind crossover study of domperidone and prochlorperazine suppositories for controlling emesis in outpatients receiving chemotherapy.

Olver IN, Laidlaw CR, Matthews JP, Bishop JF, Hayes AM, Wolf M, Toner GC. Olver IN, et al. Eur J Cancer. 1994;30A(4):426-9. doi: 10.1016/0959-8049(94)90411-1. Eur J Cancer. 1994. PMID: 8018396 Clinical Trial.

10

Low-dose versus standard-dose lenograstim prophylaxis after chemotherapy: a randomized, crossover comparison.

Toner GC, Shapiro JD, Laidlaw CR, Rischin D, Millward MJ, Wolf M, Januszewicz H, Mitchell SV, Curran AC, Matthews JP, Bishop JF. Toner GC, et al. J Clin Oncol. 1998 Dec;16(12):3874-9. doi: 10.1200/JCO.1998.16.12.3874. J Clin Oncol. 1998. PMID: 9850033 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

205 results

Search Page

Filters